Literature and evidence database
Find the source, the model and the boundary.
Search source records connected to the product-family knowledge base. Filter by category, product, publication year, research type, study model and editorial evidence tier.
Product evidence maps
A focused source set for each product.
Search and filter
Evidence records
Narrow the records by product, year or study model. Open each source to check its results and limitations.
Bachem: peptide notation and terminal modifications
Bachem: peptide notation and terminal modifications. Accessed 2026-10-03.
Bachem: Quality Control of Amino Acids and Peptides
Bachem: Quality Control of Amino Acids and Peptides. Accessed 2026-10-05.
Keratinocyte migration and EGFR signaling — 2005 original study
Original study; checked 2026-10-05.
Thermo Fisher: Peptide Analyzing Tool and its limitations
Checked 2026-10-05; source scope is identified in the article.
Thermo Fisher: Peptide Design guide
Checked 2026-10-05; source scope is identified in the article.
FDA: ICH Q6A, specifications and acceptance criteria
Checked 2026-10-05; source scope is identified in the article.
JPT: Peptide Quality & Purity
Checked 2026-10-05; source scope is identified in the article.
FDA: Pyrogen and Endotoxins Testing, Edition 2
Checked 2026-10-05; source scope is identified in the article.
Thermo Fisher: chromatographic separation of isobaric leucine and isoleucine
Checked 2026-10-05; source scope is identified in the article.
Agilent: Five Tips for Chromatographic Integration
Agilent: Five Tips for Chromatographic Integration. Accessed 2026-10-05.
LL-37 antimicrobial activities under different salt conditions
Checked 2026-10-05; source scope is identified in the article.
Jin et al., Nanoscale (2026): Molecular interaction modes of the host-defense peptide cathelicidin LL-37 and its mutants dictate diverse antimicrobial activities
Original publication; reported findings apply to its study material and model. Checked 2026-10-04.
JPT: peptide pools and matrix layouts
JPT: peptide pools and matrix layouts. Accessed 2026-10-03.
Analytical Procedures and Methods Validation for Drugs and Biologics
U.S. Food and Drug Administration. Guidance for Industry, July 2015.
Primary publication — PubMed 18061177
Dalmasso G et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134(1):166–178. PMID 18061177.
LL-37 ocular-surface expression and antimicrobial activity
Gordon YJ, et al. Current Eye Research. 2005. PMID 16020269.
Certain Bulk Drug Substances That May Present Significant Safety Risks
U.S. FDA. Current compounding safety-information page.
Care and handling of peptides
Care and handling of peptides
Targeted delivery of antimicrobial peptide LL-37 via ferritin fusion improves antibacterial and anti-inflammatory outcomes in a murine sepsis model.
Targeted delivery of antimicrobial peptide LL-37 via ferritin fusion improves antibacterial and anti-inflammatory outcomes in a murine sepsis model.
Coordination chemistry and antimicrobial activity of LL-37, its C-terminal fragment, and a peptidomimetic analogue.
Coordination chemistry and antimicrobial activity of LL-37, its C-terminal fragment, and a peptidomimetic analogue.
Peptide Isolation – Method Development Considerations
Peptide Isolation – Method Development Considerations
LL-37 analog activity, cytotoxicity and serum inhibition
In-vitro context; PMID 15980359.
Solubility Guidelines for Peptides
Solubility Guidelines for Peptides
LL-37, self-DNA and plasmacytoid dendritic cells
LL-37, self-DNA and plasmacytoid dendritic cells
Editorial methodology
How records are classified
Records are deduplicated by source URL and linked to every relevant product family. Study type and model are inferred from the citation and editorial evidence label, then reviewed during content QA.
Read the full editorial, AI-assistance and correction policy →
Labels and databases supporting regulatory status, formulation or chemical identity.
Controlled trials, systematic reviews and other clinical records with population-specific interpretation.
Animal, cell, analytical and mechanistic records that cannot establish human outcomes.
Narrative reviews, registries and sponsor reports kept visibly distinct from peer-reviewed outcomes.
Use the records
